One hundred clinical isolates of Sporothrix schenckii were tested against v
oriconazole, itraconazole and amphotericin B using a modification of the NC
CLS M27-A in vitro yeast susceptibility testing procedure. NCCLS M38-P for
moulds was not used because yeast forms may have been present when the test
isolates were incubated at 35 +/-1 degreesC. The minimum inhibitory concen
tration (MIC) values were: voriconazole 0.5-8 (geometric mean titer 6.50) m
ug ml(-1); itraconazole 0.03-8 (geometric mean titer 1.56) mug ml(-1); and
amphotericin B 0.25-2 (geometric mean titer 1.23) mug, ml(-1). The minimum
fungicidal concentration (MFC) values were: voriconazole 2-8 (geometric mea
n titer 7.67) mug ml(-1); itraconazole 0.125-8 (geometric mean titer 7.41)
l mug ml(-1); and amphotericin B 0.125-2 (geometric mean titer 1.53) mug ml
(-1). Based upon MIC values, sensitivity to amphotericin B is strain-depend
ent. S. schenckii is more sensitive to itraconazole than voriconazole based
upon a comparison of MIC geometric means, even though the MIC ranges were
essentially the same.